Polar Capital Holdings PLC Roivant Sciences Ltd. Transaction History
Polar Capital Holdings PLC
- $17.4 Billion
- Q2 2025
A detailed history of Polar Capital Holdings PLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 1,225,000 shares of ROIV stock, worth $14.2 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,225,000
Previous 2,500,000
51.0%
Holding current value
$14.2 Million
Previous $25.2 Million
45.27%
% of portfolio
0.08%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
360Shares Held
447MCall Options Held
8.17MPut Options Held
725K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...